E. van Hoogdalem, C.A. Daykin, J. van der Greef et al , Development of Gene Expression and Proteomic Biomarkers for Clinical Proof-of-Concept Testing in Type 2 Diabetes Mellitus, BioPharm Meeting 2003, New Jersey, USA.
C.A. Daykin, Metabonomics and the Healthcare Industry: What? Why? And How?, 2nd International Conference on Biomedical Spectroscopy, London, UK.